InsidersTradesSigma
Explore the full record of transactions filed by Wilhoit Scott L., Directeur Commercial. Officer active across 2 companies, notably Strongbridge Biopharma plc. Aggregated, 4 filings have been recorded. The latest transaction was disclosed on 1 October 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Scott L. Wilhoit is the Chief Commercial Officer of Strongbridge Biopharma plc. He is responsible for the company's commercial strategy and business development. His role is essential in ensuring revenue growth and market expansion. Scott brings expertise in commercial strategy and product development.